Related Experiment Video
Updated: Dec 24, 2025
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
13.0K
Evolving Pharmacotherapies for Pain: Drug Development.
Rohit Nalamasu1, Srinivas Nalamachu2
1Physical Medicine and Rehabilitation, University of Nebraska, 986155 Nebraska Medical Center, Omaha, NE 68198-6155, USA.
Summary
Millions suffer from chronic pain, a major public health issue. This article explores novel molecular treatments and advanced delivery systems for chronic pain management.
Area of Science:
- Pain research
- Pharmacology
- Public health
Background:
- Chronic pain affects over 100 million Americans, representing a significant public health crisis.
- It is a leading cause of disability and disproportionately impacts women, low-income individuals, and older adults.
- Current management strategies have limitations, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review emerging molecular entities targeting chronic pain pathways.
- To discuss advancements in drug delivery technologies for pain management.
- To highlight potential future treatments for the chronic pain epidemic.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of preclinical and clinical data on new molecular entities.
- Examination of innovative drug delivery systems for pain therapeutics.
Main Results:
- Several novel molecular targets for chronic pain are under investigation.
- New delivery technologies aim to improve drug efficacy and patient compliance.
- Emerging therapies show promise in addressing unmet needs in chronic pain management.
Conclusions:
- Advancements in molecular science and delivery technology offer new hope for chronic pain patients.
- Targeted therapies and innovative delivery systems are crucial for combating the chronic pain epidemic.
- Continued research is essential to translate these developments into effective clinical practice.
Related Concept Videos
01:25Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
816
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
816
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
752
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
752
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
01:26Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
01:24Principles of Drug Action
7.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.8K